简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Why OTR Acquisition Shares Are Soaring Today

2022-05-13 19:40

Shares of a SPAC are trading significantly higher Friday after a large portion were redeemed as part of the SPAC process.

What Happened: OTR Acquisition Corp (NASDAQ:OTRA) completed Thursday its merger vote with Comera Life Sciences.

A total of 10.3 million shares, representing 98.4% of all OTR Acquisition shares were redeemed as part of the merger. As a result, only 168,000 shares of OTR Acquisition remain tradeable.

“Up there with one of the highest % redemptions on record,” SPAC expert Julian Klymochko tweeted.

There is no PIPE funding on the SPAC deal, which could increase the chances that the company needs to do financing to fund future growth as it will get a fraction of the proceeds it originally projected. There is also some risk that the deal will close given the low capital and high redemptions.

Comera is developing biologic medicines to improve safety for patient using its formulation platform SQore. The company said it was planning to collaborate with pharmaceutical and biotechnology companies when it announced its SPAC deal.

Companies that have low floats and have completed their SPAC vote have often traded higher and seen several halts.

OTRA Price Action: OTR Acquisition shares were up 105% to $20.30 in after-hours trading Thursday; In Friday's premarket session, the stock was up about 46% at press time.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。